1351167-70-8

Basic information

• Product Name: (S)-3-(2-fluoro-4-(methylsulfonyl)phenylamino)-1-(1-(5-methoxypyrazin-2-yl)piperidin-4-yl)pyrrolidin-2-one
• Synonyms: (S)-3-(2-fluoro-4-(methylsulfonyl)phenylamino)-1-(1-(5-methoxypyrazin-2-yl)piperidin-4-yl)pyrrolidin-2-one
• CAS NO: 1351167-70-8
• Molecular Weight: 463.533
• Mol File: 1351167-70-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (S)-3-(2-fluoro-4-(methylsulfonyl)phenylamino)-1-(1-(5-methoxypyrazin-2-yl)piperidin-4-yl)pyrrolidin-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-3-(2-fluoro-4-(methylsulfonyl)phenylamino)-1-(1-(5-methoxypyrazin-2-yl)piperidin-4-yl)pyrrolidin-2-one(1351167-70-8)
• EPA Substance Registry System: (S)-3-(2-fluoro-4-(methylsulfonyl)phenylamino)-1-(1-(5-methoxypyrazin-2-yl)piperidin-4-yl)pyrrolidin-2-one(1351167-70-8)

Safety Data

• Hazardous Substances Data: 1351167-70-8(Hazardous Substances Data)

Upstream product

• 1351167-91-3 (S)-benzyl 4-(3-(2-fluoro-4-(methylsulfonyl)phenylamino)-2-oxopyrrolidin-1-yl)piperidin-1-carboxylate 
• 1351167-90-2 (S)-benzyl 4-(3-amino-2-oxopyrrolidin-1-yl)piperidin-1-carboxylate 
• 1351167-89-9 (S)-benzyl 4-(3-(tert-butoxycarbonylamino)-2-oxopyrrolidin-1-yl)piperidin-1-carboxylate 
• 1351167-88-8 (S)-(4-(1-(benzyloxycarbonyl)piperidin-4-ylamino)-3-(tert-butoxycarbonylamino)-4-oxobutyl)dimethylsulfonium iodide 
• 143250-10-6 2-bromo-5-methoxypyrazine 
• 1351167-86-6 (S)-3-(2-fluoro-4-(methylsulfonyl)phenylamino)-1-(piperidin-4-yl)pyrrolidin-2-one 
• 120278-07-1 benzyl 4-aminopiperidine-1-carboxylate 

Relevant articles and documents

PIPERIDINYL-SUBSTITUTED LACTAMS AS GPR119 MODULATORS

Compounds of Formula (I): and pharmaceutically acceptable salts thereof in which X1, X2, L, R3, R4, R5, R6, R6a, R7, R9, R9a, and n have the meanings given in the specification, are modulators of GPR119 and are useful in the treatment or prevention of diseases such as such as, but not limited to, type 2 diabetes, diabetic complications, symptoms of diabetes, metabolic syndrome, obesity, dyslipidemia, and related conditions.